Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5
Infectious Diseases and Clinical Microbiology · 2022
DOI: 10.36519//idcm.2022.143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infectious Diseases and Clinical Microbiology, 2022. Verfasst von Yesim Tuyji-Tok und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tuyji-Tok, Y., Yücebag, E., Keles, A. B., Kılınçarslan, A. C., Nohut, O. K., Salman-Yılmaz, S., Kuskucu, M. A., & Midilli, K. (2022). Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5. Infectious Diseases and Clinical Microbiology. https://doi.org/10.36519//idcm.2022.143
Vancouver
Tuyji-Tok Y, Yücebag E, Keles AB, Kılınçarslan AC, Nohut OK, Salman-Yılmaz S, et al. Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5. Infectious Diseases and Clinical Microbiology. 2022. doi:10.36519//idcm.2022.143
BibTeX
@article{TuyjiTok2022,
author = {Tuyji-Tok, Yesim and Yücebag, Ebru and Keles, Ayse Betül and Kılınçarslan, Ayşe Ceylan and Nohut, Okan Kadir and Salman-Yılmaz, Seda and Kuskucu, Mert Ahmet and Midilli, Kenan},
title = {Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5},
journal = {Infectious Diseases and Clinical Microbiology},
year = {2022},
doi = {10.36519//idcm.2022.143}
}
EUVIMED